c—erbB—2、p53及nm23基因及产物在乳腺癌预后中的意义

被引：13

作者：

刘晓光

徐光炜

机构：

[1] 北京市肿瘤防治研究所

来源：

中国肿瘤临床 | 1994年 / 05期

关键词：

乳腺癌; 乳腺肿瘤; nm23; erbB; 基因; 产物;

D O I：

暂无

中图分类号：

R737.9 [乳腺肿瘤];

学科分类号：

摘要：

<正>乳腺癌预后的判断是一众所关注的问题.目前虽有很多预测预后的方法:如肿瘤大小、组织学、核分级、激素受体、细胞增殖率、核倍体、生长因子受体、上皮生长因子受体基因及CathepsinD产物等等,但仍不能十分有效的判断预后.最近美国国立癌瘤中心发展联合会提出一项标准:肿瘤<1cm且无淋巴结转移的乳腺癌病人,术后10年复发率<10%,因此不必进行系统治疗,已被大家公认.然而>1cm乳腺癌病人预后判断仍需作进一步研究.本文综述近年来大家研究较多,并对乳腺癌预后判别较重要的的P53基因、C—

引用

页码：76 / 80

页数：5

共 17 条

[1]

Germ line P53 mutations in a familial syndrome of breast cancer,sarcomas and other neoplasms. Malkin D et al. Science . 1990

[2]

P53 expression in hunman breast cancer related to survival and prognostic factors:an immunohistochemical study. Ostrowski-J L et al. Journal of Paleopathology . 1991

[3]

Expression of c-erbB-2 oncoprotein:a prognostic indicator in human breast cancer. Wright C et al. Cancer Research . 1989

[4]

Evidence for a novel gene associated with low tumor metastatic potential. Steeg P S et al. Journal of the National Cancer Institute . 1988

[5]

Genetic basis for P53 overexpression in human breast cancer. Andrew M et al. Proceedings of the National Academy of Sciences of the United States of America . 1991

[6]

Human breast cancer:correlations of relapse and survival with amplification of the HER-2 ney nocogene. Slamon et al. Science . 1987

[7]

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma. Barnes D M et al. British Journal of Cancer . 1988

[8]

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and univolved lymph nodes. Gullick W J et al. British Journal of Cancer . 1990

[9]

c-erbB-2 expression in benign and malignant breast disease. Gusterson et al. British Journal of Cancer . 1988

[10]

T antigen is bound to a host protein in SV40-transformed cells. Lane D P et al. Nature . 1979

← 1 2 →